TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Alto Neuroscience Stock

Alto Neuroscience Stock

altoneuroscience.comHealthcareFounded: 2019Funding to Date: $101.8MM

Alto Neurosciences is a biopharma company that uses biomarkers of the brain to understand prospective drug therapies for psychiatric care of patients. Alto Neurosciences specializes in precision medicine, and has established a pipeline of treatments for various mental health conditions such as post-traumatic stress disorders (PTSD) and depression.

Buy or sell Alto Neuroscience stockLearn more about Alto Neuroscience IPO
Register for Details

For more details on financing and valuation for Alto Neuroscience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Alto Neuroscience.

Register Today

Alto Neuroscience investors also invested in these private companies

Valor Equity Partners
Gaingels
Vine Ventures
What If Ventures
Novartis
Windham Venture Partners
Sobrato Capital
Korify Capitals

Team

Management Team

Amit Etkin, MD, PhD
Founder and Chief Executive Officer
Dan Segal
Co-Founder and Chief Strategy Officer
Adam Savitz, MD, PhD
Chief Medical Officer
Wei Wu, PhD
Co-Founder and Chief Data Science Officer
Nick Smith
Chief Financial Officer
MIkael Eliasson, MD, PhD
Chief Operating Officer

Board Members

Gwill York, MBA
Lighthouse Capital Partners
Aaron Weaver
Apeiron Investment Group
Jeff Chen, PhD
Alkeon Capital Management
Christopher Nixon Cox, JD
Lightswitch Capital

Other companies like Alto Neuroscience in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Colossal Biosciences
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
Headspace
Sector
Healthcare
Last Round Est. Valuation
$298.33MM
OURA
Sector
Healthcare
 
 
Allurion Technologies
Sector
Healthcare
 
 

News

Businesswire 10/31/2022
Alto Neuroscience Announces $35 Million Series B Financing
Alto Neuroscience today announced the closing of a $35 million Series B financing led by Lightswitch Capital and partners of Alkeon Capital, with participation from other new investors including Sobrato Capital, Novartis Pharma AG, Valor Equity Partners, Korify Capital, Vine Ventures, and Gaingels.

Trending Companies

Frequently Asked Questions